PubRank

Eugene Tulchinsky

Author PubWeight™ 21.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 2005 3.41
2 A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 2013 2.46
3 Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell 2007 1.71
4 SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci U S A 2009 1.56
5 Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004 1.44
6 ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer 2012 1.43
7 Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1). J Biol Chem 2001 1.34
8 ZEB proteins link cell motility with cell cycle control and cell survival in cancer. Cell Cycle 2010 1.23
9 Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol Cell Biol 2005 1.15
10 Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene 2004 1.05
11 The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials. Oncogene 2002 0.98
12 Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21. J Biol Chem 2012 0.98
13 Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility. Oncogene 2003 0.94
14 Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays. Exp Mol Pathol 2010 0.90
15 Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. Int J Oncol 2009 0.90
16 Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB. Oncotarget 2013 0.79